FDA wants to end pediatric priority review program

Friday, March 11, 2016 - 13:11 in Health & Medicine

Benefits in advancing drugs for rare diseases is questioned

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net